CS logo
small CS logo
Uni Hospital Linkoeping; Dept. of Oncology

Linkoping, Sweden
University hospital in Linköping
Universitetssjukhuset, 581 85 Linköping

About Uni Hospital Linkoeping; Dept. of Oncology


Linköping University Hospital is a university hospital in Linköping, Sweden, operated by Östergötland County. Its scientific activities are integrated into the medical faculty of Linköping University. The hospital has all specializations except organ transplantation.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
University Hospital, Linkoeping
2
Collaborative Group for Adrenocortical Carcinoma Treatment
1
Göteborg University
1
Rectal Cancer Trial on Defunctioning Stoma Study Group
1
Regionalt Cancercentrum Väst
1
The Christie NHS Foundation Trust
1
Total Rows: 7

Clinical Trials at Uni Hospital Linkoeping; Dept. of Oncology


During the past decade, Uni Hospital Linkoeping; Dept. of Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001100110000112211111111000000Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
2004-06-01
2010-12-01
Completed
304
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction
2006-01-01
2010-08-01
Completed
400
Rectal Cancer Trial On Defunctioning Stoma
1999-12-01
Completed
234
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
2009-06-25
2013-07-01
Completed
190
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Uni Hospital Linkoeping; Dept. of Oncology" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "University Hospital, Linkoeping" with 2 trials sponsored, "Collaborative Group for Adrenocortical Carcinoma Treatment" with 1 trials sponsored, "Göteborg University" with 1 trials sponsored and "Rectal Cancer Trial on Defunctioning Stoma Study Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uni Hospital Linkoeping; Dept. of Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7University Hospital,Linkoeping: 2University Hospital,Linkoeping: 2Collaborative Group forAdrenocorticalCarcinoma Treatment: 1Collaborative Group forAdrenocorticalCarcinoma Treatment: 1Göteborg University: 1Göteborg University: 1Rectal Cancer Trial onDefunctioning StomaStudy Group: 1Rectal Cancer Trial onDefunctioning StomaStudy Group: 1Regionalt Cancercentrum Väst: 1Regionalt Cancercentrum Väst: 1The Christie NHSFoundation Trust: 1The Christie NHSFoundation Trust: 1

Created with Highcharts 11.1.0Top CollaboratorsGenentech, Inc.: 2Genentech, Inc.: 2Breast International Group: 1Breast International Group: 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1GOG Foundation: 1GOG Foundation: 1German FederalMinistry of Educationand Research: 1German FederalMinistry of Educationand Research: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1Region Jönköping County: 1Region Jönköping County: 1Sahlgrenska UniversityHospital, Sweden: 1Sahlgrenska UniversityHospital, Sweden: 1Västervik Hospital: 1Västervik Hospital: 1

Clinical Trials Conditions at Uni Hospital Linkoeping; Dept. of Oncology


According to Clinical.Site data, the most researched conditions in "Uni Hospital Linkoeping; Dept. of Oncology" are "Breast Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Bile Duct Cancer" (1 trials) and "Bile Duct Obstruction" (1 trials). Many other conditions were trialed in "Uni Hospital Linkoeping; Dept. of Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Uni Hospital Linkoeping; Dept. of Oncology


Most popular intervention types in "Uni Hospital Linkoeping; Dept. of Oncology" are "Drug" (9 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Doxorubicin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Uni Hospital Linkoeping; Dept. of Oncology


The vast majority of trials in "Uni Hospital Linkoeping; Dept. of Oncology" are 9 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Uni Hospital Linkoeping; Dept. of Oncology


Currently, there are NaN active trials in "Uni Hospital Linkoeping; Dept. of Oncology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Uni Hospital Linkoeping; Dept. of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uni Hospital Linkoeping; Dept. of Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1